Universal Biosensors (ASX:UBI) signed a non-exclusive deal with Henry Schein, an American distributor of dental and medical supplies, according to a Friday filing with the Australian bourse.
The agreement covers the distribution of the company's coagulation monitoring device, Xprecia Prime, throughout the US, the filing said.
The deal is for a year with provisions for annual extensions by agreement, as per the filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.